Calcium Handling Kinetics Behind Post-Extrasystolic Potentiation in Cardiac Pacing
The companion article on AV delay optimization introduced a composite rate constant k governing the magnitude of post-extrasystolic potentiation (PESP) in the equation ΔSVn+1 ≈ SVmax · (1 − e−k·ΔAV). That constant was treated as a patient-specific "black box." This article opens the box.
The constant k is a composite of at least four measurable molecular rate constants that govern how fast the sarcoplasmic reticulum (SR) loads calcium, how much it can hold, how readily it releases on the next beat, and how much calcium is lost from the cell entirely. Understanding these four parameters transforms PESP from a clinical observation into a mechanistically predictable phenomenon—and explains why PESP is amplified during exercise, attenuated in heart failure, and has a finite temporal decay.
The Four Rate Constants Inside k
SERCA2a (sarco/endoplasmic reticulum Ca²⁺-ATPase, isoform 2a) is the molecular pump that moves cytosolic calcium back into the SR lumen during diastole. It is the single most important determinant of how efficiently the SR "super-loads" after a hemodynamically compromised beat.
At baseline, SERCA2a is tonically inhibited by phospholamban (PLB), a small transmembrane protein that physically associates with the pump and reduces its affinity for calcium. Under β-adrenergic stimulation—the dominant neurohormonal state during exercise—protein kinase A (PKA) phosphorylates PLB at serine-16 (Ser16), causing PLB to dissociate from SERCA2a. This relieves inhibition and increases the pump’s maximum velocity (Vmax) by 2–3×.
There is a second phosphorylation site: threonine-17 (Thr17), phosphorylated by calcium/calmodulin-dependent protein kinase II (CaMKII). This provides a frequency-dependent boost—the faster the heart rate, the more calcium enters per unit time, the more CaMKII is activated, and the more PLB Thr17 is phosphorylated. This creates a positive feedback loop that augments SR calcium loading specifically at high heart rates.
SR reuptake time: ~200 ms (rest) → ~80 ms (peak sympathetic drive)
Affinity shift: KCa decreases from ~0.8 μM to ~0.3 μM with PLB phosphorylation
Calsequestrin (CASQ2) is the high-capacity, low-affinity calcium buffer inside the SR lumen. As luminal [Ca²⁺] rises, CASQ2 polymerizes into linear chains, dramatically increasing the effective storage capacity. Total SR calcium content can reach approximately 20 mM (mostly buffered by CASQ2), while free luminal [Ca²⁺] remains around 1 mM.
The PESP phenomenon depends on CASQ2 not being at capacity—there must be headroom to accept the "extra" calcium that wasn’t consumed during the compromised beat’s abbreviated cross-bridge cycling. In healthy myocardium, the SR normally operates at 60–70% of its maximum capacity, leaving substantial headroom. In heart failure, CASQ2 expression is often reduced, total SR calcium content is lower, and the ceiling for super-loading is diminished. This is one reason PESP magnitude is attenuated in HFrEF—the molecular "bucket" is already smaller, so the fractional increase from a single bad beat is proportionally less.
PESP super-loaded: 80–90% of capacity
Total buffered [Ca²⁺]: ~20 mM · Free luminal [Ca²⁺]: ~1 mM
HFrEF CASQ2: Expression ↓ 30–50% → reduced PESP headroom
The relationship between SR calcium load and calcium release is nonlinear—it follows what is called the "SR load–release relationship." As luminal [Ca²⁺] rises, it sensitizes RyR2 channels via luminal calcium sensing, primarily through the CASQ2–triadin–junctin complex interaction with RyR2. The relationship is roughly sigmoidal.
At normal SR loads (~60–70% capacity), fractional release is about 50–60%. At the super-loaded states seen during PESP (~80–90% capacity), fractional release can jump to 70–85%. This is the "gain amplification"—the reason PESP overshoots rather than merely normalizing. The gain curve is steep in this operating region, meaning small increases in SR load produce disproportionately large increases in calcium release and therefore contractile force.
During exercise, CaMKII phosphorylation of RyR2 at Ser2814 increases baseline open probability, further steepening the gain curve. This is physiologically appropriate (it increases contractile reserve) but also means the PESP effect is amplified at exercise heart rates.
PESP fractional release: 70–85% of SR content
Gain amplification: Sigmoidal; steep between 70–90% SR load
CaMKII effect: RyR2 Ser2814 phosphorylation ↑ Popen
The sodium-calcium exchanger (NCX, primarily NCX1) competes with SERCA2a for cytosolic calcium during diastole. In healthy human myocardium, SERCA2a handles approximately 70% of cytosolic calcium removal (recycling it to the SR), while NCX handles approximately 25% (extruding it from the cell in exchange for sodium). The remaining ~5% is managed by the mitochondrial calcium uniporter and sarcolemmal Ca²⁺-ATPase.
The SERCA2a/NCX ratio is critical for PESP magnitude. A higher ratio means more calcium stays intracellular (available for SR recycling) rather than being extruded, favoring SR super-loading. In heart failure, SERCA2a is downregulated while NCX is upregulated—the ratio shifts from approximately 3:1 to approximately 1.5:1. This means more calcium leaves the cell entirely on each beat, and the SR super-loading mechanism is partially short-circuited.
HFrEF ratio: SERCA2a 50% / NCX 40% / Other 10%
Net effect in HF: ↓ SR recycling, ↓ PESP headroom, ↓ potentiation
The Composite Equation
With the four rate constants identified, the composite constant k from the PESP model can be decomposed:
β-Adrenergic Amplification During Exercise
The practical consequence: AV dyssynchrony that is hemodynamically silent at rest (small offset, low k, minimal PESP) can produce dramatic beat-to-beat oscillation during exercise because the same offset interacts with a system whose k is 2–3× larger. This is why some LBBAP patients report "stumbling" or pulsatile irregularity specifically during sustained effort but not at rest.
Time-Dependence: PESP Decay Kinetics
The SR super-loading that drives PESP is not permanent. It dissipates over subsequent beats as steady-state calcium cycling re-establishes. The decay follows the number of intervening normally-timed beats:
| Pattern | Beats Affected | PESP Behavior | Clinical Consequence |
|---|---|---|---|
| Single dyssynchronous beat | n+1 maximal, n+2 attenuated, n+3 gone | Transient overshoot, self-resolving in 2–4 beats | Usually imperceptible. Occasional PVC-like sensation. |
| Alternating dyssynchrony (beat-to-beat) | Sustained—every odd beat re-loads the SR | Continuous pulsus alternans. System never reaches steady state. | Exercise intolerance, perceived pulsatile irregularity. Requires AV delay reprogramming. |
| Sustained dyssynchrony (every beat) | PESP disappears within 3–5 beats | New lower steady state. No compensatory overshoot. | Worst scenario. Chronic hemodynamic compromise without compensation. May mimic heart failure decompensation. |
Sustained dyssynchrony (scenario 3) is the most dangerous because the clinician may attribute the hemodynamic compromise to worsening heart failure rather than a programming error. The diagnostic clue: if the patient had a recent AV delay change or their heart rate recently crossed the threshold where rate-adaptive AV shortening engages aggressively, suspect timing mismatch before escalating heart failure therapy.
Pathological Edge Cases
Store-Overload Induced Calcium Release (SOICR)
If SR load exceeds approximately 90–95% of capacity, RyR2 channels begin opening spontaneously—a phenomenon called store-overload induced calcium release (SOICR). These uncontrolled releases produce delayed afterdepolarizations (DADs) via NCX-generated inward current (the exchanger extrudes the released calcium in exchange for sodium, producing a net depolarizing current). If DAD amplitude reaches threshold, triggered activity ensues.
In practice, a single PESP event in normal myocardium rarely reaches SOICR threshold because the SR load goes from ~65% to ~80–85%—well below the 90–95% danger zone. However, three populations are at elevated risk:
1. RyR2 gain-of-function mutations (catecholaminergic polymorphic ventricular tachycardia, CPVT): SOICR threshold is lower because RyR2 channels are inherently leaky. Even modest SR super-loading can trigger spontaneous release. These patients are typically already identified by clinical phenotype, but the implication is that AV dyssynchrony during exercise (which maximizes both PESP and catecholamine drive) is particularly dangerous in this population.
2. Digitalis toxicity: Cardiac glycosides inhibit Na⁺/K⁺-ATPase, raising intracellular [Na⁺], which reduces NCX-mediated calcium extrusion, indirectly loading the SR. This brings baseline SR calcium closer to the SOICR threshold.
3. Heart failure with altered RyR2 phosphorylation: Chronically hyperphosphorylated RyR2 (PKA at Ser2808, controversial) may have increased leak at lower SR loads. Paradoxically, while total SR calcium content is reduced in HF, the threshold for spontaneous release may also be reduced, narrowing the safe operating window.
The SERCA2a/NCX Ratio in Heart Failure
The shift from a 3:1 to a 1.5:1 SERCA2a/NCX ratio in heart failure has implications beyond just reducing PESP magnitude. It fundamentally alters the beat-to-beat calcium balance: more calcium leaves the cell per beat (via NCX), requiring more calcium entry per beat (via L-type calcium channels) to maintain steady state. This makes the system more dependent on trans-sarcolemmal calcium flux and less dependent on SR cycling. The practical consequence is that PESP—which is entirely an SR phenomenon—becomes a proportionally smaller contributor to beat-to-beat contractile modulation in heart failure, even when AV dyssynchrony is substantial.
This has a counterintuitive clinical implication: in the HFrEF patient with LBBAP, AV delay optimization matters more (because every mL of stroke volume counts) but PESP compensation matters less (because the SR machinery is impaired). There is less "forgiveness" in the system—a suboptimal AV delay will not generate the same compensatory overshoot that a patient with normal calcium handling would experience. The penalty for poor AV timing is more linear and less self-correcting.
The SERCA2a/NCX ratio is species-dependent. Human and rabbit are roughly 70/25 (SERCA2a-dominant). Mouse and rat are approximately 92/7 (extremely SERCA2a-dominant), which is why rodent models tend to overestimate PESP magnitude and underestimate the effect of NCX upregulation in heart failure translational studies. Clinical LBBAP literature reflects human ratios.
Frequently Asked Questions
PESP is driven by four interacting molecular rate constants: SERCA2a pump rate (how fast the SR reloads calcium), calsequestrin buffering capacity (the SR storage ceiling), RyR2 open probability and gain (how much stored calcium is released on the next beat), and NCX competition (what fraction of cytosolic calcium is extruded vs. recycled). When a hemodynamically compromised beat produces less mechanical work, SERCA2a continues pumping but less calcium is consumed by cross-bridge cycling, creating a transiently super-loaded SR.
β-adrenergic stimulation causes PKA phosphorylation of phospholamban, increasing SERCA2a Vmax by 2–3×. CaMKII phosphorylation of RyR2 steepens the gain curve. Together, these increase the composite rate constant k by roughly 2–3× during exercise vs. rest, meaning AV dyssynchrony that is silent at rest can produce dramatic beat-to-beat oscillation during exercise.
In normal myocardium, a single PESP event rarely reaches the threshold for store-overload induced calcium release (SOICR). However, patients with CPVT (RyR2 gain-of-function mutations), digitalis toxicity, or severe heart failure with altered RyR2 phosphorylation have lower SOICR thresholds. For the typical LBBAP patient with structurally normal or mildly impaired myocardium, PESP-related arrhythmia is theoretical rather than practical.